Profile banner
Mark Gannott

Mark Gannott

Fractional CFO | Health Economics & Outcomes | Life Science Valuation

mark-gannott-7129
Joined March 2026
Favicon imagelinkedin.comFavicon imageinstagram.comFavicon imageplatform.dkv.globalFavicon imageaihardwaresummit.com

Network

15.9K connections

Summary

Mark Gannott is a dedicated pharmacoeconomist with a unique academic background in neuroscience and economics, passionately focusing on the financial and societal impact of underfunded health issues, particularly in women's health. His career trajectory was profoundly shaped by a personal tragedy, shifting his focus from medical school to healthcare financing, driven by a desire to make an 'upstream difference' by addressing funding gaps in critical health areas. simplecast+1
As the CEO and Co-Founder of Rogue Insights and Solutions, Mark leverages his expertise to craft innovative solutions for seed-stage to mature companies in life sciences. His work specifically targets women's health, biotechnology, and medtech, providing strategic guidance in health economics, investor relations, and valuation. He actively contributes to the discourse around women's health, presenting at global conferences and being quoted in publications like Forbes on the economic burden of conditions such as PCOS and endometriosis. linkedin+2
Mark is an active academic contributor and researcher, holding an Adjunct Fellow position at Western Sydney University. He co-authors significant studies on the economic impact of menstrual symptoms and the cost of endometriosis and chronic pelvic pain, demonstrating his commitment to advancing scientific understanding and policy in these often-overlooked health sectors. nih+2
Beyond his professional and academic pursuits, Mark manages a successful animal-humor social media conglomerate, Floof Labs, including accounts like '@doggosbeingdoggos'. This side project, which has garnered millions of followers and billions of views, highlights his diverse interests and commitment to promoting mental well-being through lighthearted content. dkv+1

Work

Education

Writing

The Cost of Endometriosis and Chronic Pelvic Pain Burden in New Zealand (Aotearoa): Results from a Nationwide Survey

January 1, 2025

This study provides the first nationwide estimate of the economic and personal burdens of endometriosis and chronic pelvic pain (CPP) in New Zealand, adopting a societal perspective. It incorporates direct healthcare costs, productivity losses, and carer burden, finding a macroeconomic cost of $12.67B-17.73B INT, with productivity losses as the dominant cost driver.

Favicon imagepapers.ssrn.com

Problematic Periods Costing Young Women-The Impact of Menstrual Symptoms on Work and Study

January 1, 2024

This study used a cross-sectional design to investigate menstrual symptom prevalence, impacts and economic burden in Australian women of reproductive age. It found that most respondents (77%) reported bothersome menstrual symptoms, and almost half (44%) reported missed days of work or study. The economic burden due to menstrual symptoms was approximately AUD $14.2 billion per year.

Favicon imagepubmed.ncbi.nlm.nih.gov

Hobbies

Manages popular animal-humor social media pages like '@doggosbeingdoggos' and 'Floof Bork Snoot ‘N’ Boop', which promote mental health. dkv+1

Similar profiles

MG

Mark Gannott

Advisor at Eir Accelerator by Women's Health Hub Finland

FN

Freddy Nguyen

Physician-Scientist Fellow, Institute for Medical Engineering and Science at Massachusetts Institute of Technology

DN

Doug Nissinoff

BB

Brittany Barreto

Fractional Operator - Consultant - Advisor at Freelance

TS

Toot Shani

Member at PEF Community

BB

Brian Bell

Founder and Managing Partner at Team Ignite Ventures